Drug Database
SC

SC-001 (SP009 / SC001)

✓ Approved

Declion Pharmaceuticals · · 多肽类

什么是 SC-001?

SC-001 是一种多肽类,由Declion Pharmaceuticals研发。该药已获批,用于治疗相关适应症,给药途径:Injectable (Others)、Intradermal Injection。

药物档案

商品名SP009, SC001
公司Declion Pharmaceuticals
药物类别多肽类
给药途径Injectable (Others), Intradermal Injection
状态Approved

作用机制

分子靶点

SC-001 作用于 1 个分子靶点:

()
需要更深入的分析?Noah AI 可解释复杂机制并与同类药物比较。

治疗适应症

SC-001 针对 1 个适应症,涉及 1 个治疗领域。

治疗领域疾病/病症分期
Surgical and medical proceduresBotulinum toxin injection✓ Approved

相关研究文献

PubMedNature2026-11-19

TransA-MERFISH reveals divergent post-retinal direction-selective circuits.

Wang Fei F, Zhang Lin L, Chang Siyuan S, Liu Can C et al.

A major goal in neuroscience is to map the transformation of information as it flows through the brain. For example, neurons at many levels of the visual hierarchy are attuned to motion direction1-5. However, links between motion-selective computations and cell types at various stages of the visual hierarchy remain unidentified. A key first step in delineating these relationships is to map the wiring diagrams that connect different motion-selective cell types. Here we establish a systematic, cell-type-specific circuit-mapping method, combining an anterograde trans-neuronal fluorescent tracer (mWGA-mCherry)6 with spatial transcriptomics (multiplexed error-robust fluorescence in situ hybridization (MERFISH))7,8 to establish TransA-MERFISH. We used TransA-MERFISH to comprehensively map the synaptic target cell types of four retinal ganglion cell subclasses in superior colliculus (SC) at cell-type resolution. These experiments unexpectedly revealed that retinal on-off direction-selective ganglion cells (ooDSGCs) innervate several direction-selective SC cell types, but do not innervate a SC cell type that was previously reported to display strong direction-selective responses. We validated these results using orthogonal approaches and demonstrated the sensitivity and specificity of TransA-MERFISH. Functional studies of SC activity before and after ablation of retinal direction-selective circuits confirmed that these computationally distinct, ooDSGC-dependent and -independent direction-selective cell types are commingled in SC. Together, our study establishes TransA-MERFISH as a robust framework for mapping wiring diagrams at the cell-type level and uncovers divergent computational mechanisms of motion detection in early visual processing.

PMID 43052438
阅读全文 →
PubMedNPJ digital medicine2026-11-19

Understanding mechanistic role of structural and functional connectivity in tau propagation through multilayer modeling.

Dan Tingting T, Huang Xinwei X, Ding Jiaqi J, Zheng Yinggang Y et al.

Emerging neuroimaging evidence shows that pathological tau proteins build up along specific brain networks, suggesting that large-scale network architecture plays a key role in the progression of Alzheimer's disease (AD). However, how the interaction between structural (SC) and functional connectivity (FC) is associated with tau propagation remains largely unexplored. Using longitudinal neuroimaging data, we develop a multi-layer graph diffusion model to investigate this interplay. We identify a regionally asymmetric pattern, FC dominates tau accumulation in subcortical, insular, and frontotemporal regions, whereas SC prevails in occipital, parietal, and limbic areas. The principal conduit of tau propagation shifts from FC-mediated spread in early stages to SC-constrained diffusion as the disease advances. Furthermore, these propagation patterns correlate with regional expression of AD-associated genes (e.g., CHUK, TMEM106B, MCL1, NOTCH1, TH) and are selectively modulated by risk factors like APOE genotype and biological sex. By disentangling these dynamic pathways, our framework enables personalized trajectory prediction and refined patient stratification. These findings offer mechanistic insights into selective regional vulnerability, providing a quantitative basis for stage-specific therapeutic targeting and the optimization of clinical trial designs through network-based biomarkers. Our results are validated in an independent cohort, yielding consistent findings.

PMID 43052424
阅读全文 →
PubMedCancer prevention research (Philadelphia, Pa.)2026-11-19

CONNECT: Smoking Cessation Among Individuals Receiving Lung Cancer Screening: A Pilot Study.

Walsh Judith M E JME, Kaplan Celia P CP, Brown James J, Trivedi Neil N et al.

Lung cancer screening (LCS) is recommended for high-risk individuals. Little is known about how best to promote smoking cessation (SC) among individuals receiving LCS. We conducted a pilot randomized controlled trial to assess feasibility and acceptability of a novel SC intervention, CONNECT, among individuals undergoing LCS. CONNECT includes an interactive Video Doctor providing individually tailored information and proactive outreach using brief telephone calls and text messaging. We tested CONNECT among a diverse population of people who smoke in two health care settings. Participants were randomized to CONNECT or usual care. The primary outcomes were feasibility and acceptability. Secondary outcomes included smoking status at 3 months, quit attempts, and utilization of evidence-based SC resources, including pharmacotherapy. Among 372 eligible individuals, 76 (20.4%) agreed to participate. A total of 64 completed the study, for a retention rate of 84% (64/76). Although differences were not statistically significant, more participants in the intervention group rated the video doctor (38.7% vs 20.0%) and proactive outreach (51.5% vs 37.9%) as very/extremely helpful. CONNECT participants were more likely to recommend the program to friends and family who smoke (84.6% vs 73.9%). Positive themes describing CONNECT were accountbility, motivational, informative, helpful reminders and positive interactions with personnel. Smoking outcomes (self-reported 7 day abstinence) did not differ although numbers were small (2/35 (5.7%) vs 3/29 (10.3%) people who smoke). In conclusion, a pilot study of CONNECT among a diverse population of high-risk people who smoke undergoing LCS was feasible and most would recommend it to family/friends who smoke.

PMID 43053675
阅读全文 →
PubMedEuropean heart journal. Valvular and structural heart disease2026-11-19

Care improvement by introduction of a nurse-led structured pathway in patients undergoing transcatheter aortic valve replacement: insights from a multicentre study.

D'Amario Domenico D, Cumitini Luca L, Annibali Gianmarco G, Galiffa Vincenzo V et al.

With the expanding use of transcatheter aortic valve replacement (TAVR), optimizing peri-procedural pathways to improve efficiency while maintaining safety is a clinical priority. Nurse-led structured pathways may standardize care and reduce resource utilization, but real-world data remain limited. To evaluate the impact of a nurse-led structured pathway on workflow efficiency and clinical outcomes in patients undergoing TAVR. We conducted a multicentre observational study including consecutive patients undergoing TAVR at two high-volume Italian centres across predefined periods. Outcomes after implementation of a nurse-led structured pathway were compared with those from a preceding period. The pathway included standardized pre-procedural assessment, minimalist peri-procedural management, and protocol-driven recovery. The primary endpoint was length of stay. Secondary endpoints included intensive care utilization, procedural duration, use of invasive devices, time to mobilization, transfusion requirements, and in-hospital and mid-term safety outcomes. After 1:1 propensity score matching, 150 patients were included (75 per group). The nurse-led pathway was associated with a shorter hospital stay (median 4 vs 7 days; P < .001), reduced cardiac intensive care unit length of stay (0 vs 2 days; P < .001), and higher discharge within <72 h (36% vs 20%; P = .029). Time to mobilization was shorter (24 vs 48 h; P < .001), with less use of venous introducers (53% vs 81%; P < .001), bladder catheters (39% vs 79%; P < .001), and transfusions (3% vs 25%; P < .001). In-hospital and 6-month adverse events were low and similar. A nurse-led structured pathway improves efficiency and resource utilization after TAVR without compromising safety, supporting its integration into contemporary practice.

PMID 43053819
阅读全文 →
PubMedEuropean heart journal. Valvular and structural heart disease2026-11-19

Evolution of treatment for isolated tricuspid regurgitation in the transcatheter era.

Buzzatti Nicola N, Guicciardi Nicolò Azzola NA, Gaspardone Carlo C, Denti Paolo P et al.

Tricuspid regurgitation has historically been neglected or treated too late. Outcomes of tricuspid surgery have been plagued by high mortality. Recently, transcatheter therapies have emerged as a promising alternative. To assess the changes in tricuspid regurgitation patients' referral, treatment, and in-hospital outcomes before and after transcatheter technologies became established at our centre. We retrospectively reviewed our in-hospital data from patients with isolated ≥moderate-to-severe tricuspid regurgitation referred for correction between January 2012 and December 2023. We compared two periods: before (2012-2017) and after (2018-2023) the widespread adoption of transcatheter procedures. A total of 348 patients were referred. Admissions rose from 108 (2012-2017) to 240 (2018-2023), reflecting a +12.4% annual growth (P < .001). Surgical treatment decreased from 68.5% to 37% (P < .001), while transcatheter interventions increased from 3.7% to 44% (P < .001) and indication to medical therapy alone declined from 27.8% to 19% (P = .046). Patients' risk profile remained similar over time (TriScore 7% vs 8%, P = .64). In-hospital mortality for tricuspid correction dropped from 10.3% to 3.6% (P = .039), but residual regurgitation ≥3+ rose from 2.6% to 16.3% (P < .001). After the advent of transcatheter therapies, more patients with isolated tricuspid regurgitation were referred and received correction. In the last years, transcatheter therapies became the most used method to treat tricuspid regurgitation. Procedural mortality fell, however residual regurgitation was more common. Patients' risk profile remained similar.

PMID 43053820
阅读全文 →
PubMedEuropean heart journal. Valvular and structural heart disease2026-11-19

Association between aortic arch atheroma and periprocedural stroke following transcatheter aortic valve implantation.

Suenaga Tomohiro T, Ishizu Kenichi K, Shirai Shinichi S, Yoshida Satoru S et al.

This study examined the impact of aortic arch atheroma severity on the risk of periprocedural stroke following transcatheter aortic valve implantation (TAVI). We retrospectively evaluated contrast-enhanced computed tomography data of patients who underwent transfemoral-TAVI from May 2016 to March 2024. Aortic arch atheroma was classified into none/mild [maximum plaque thickness (MPT) <3 mm], moderate (MPT 3-5 mm), severe (MPT >5 mm without shaggy morphology), and shaggy (MPT >5 mm with shaggy morphology). The primary outcome measure was periprocedural (30-day) ischaemic stroke following TAVI. Of the 1971 eligible patients, 65 (3.3%) experienced periprocedural ischaemic stroke. Compared with none/mild atheroma, moderate atheroma [adjusted odds ratio (aOR) 2.93; 95% confidence interval (CI), 1.63-5.28; P < .001] and shaggy atheroma (aOR 14.58; 95% CI, 6.67-31.87; P < .001) were independently associated with increased risk of periprocedural stroke. Severe atheroma exhibited a similar trend, albeit without statistical significance (aOR 2.81; 95% CI, 0.92-8.61; P = .07). In the balloon-expandable transcatheter heart valve (BE-THV) cohort, stroke incidence was significantly increased only in the shaggy group (1.1% vs. 2.8% vs. 1.4% vs. 11.9%, P < .001); however, stroke incidence across the atheroma severity groups in the self-expandable THV (SE-THV) cohort demonstrated a stepwise increase (2.8% vs. 8.2% vs. 13.6% vs. 33.3%, P < .001). Aortic arch atheroma severity was associated with an increased risk of periprocedural stroke following transfemoral-TAVI, with the impact being more pronounced in patients treated with SE-THV than in those treated with BE-THV.

PMID 43053867
阅读全文 →

注册免费账户还可查看另外 9996 篇文献

免费注册查看全部文献 →

了解更多SC-001